| Arca Biologistics Limited |
| Registered Number:14706868 |
For the year ended 31 March 2025
England and Wales
Unaudited Financial Statements
For the year ended 31 March 2025
Arca Biologistics Limited
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
Arca Biologistics Limited
Statement of Financial Position
2024
2025
| Property, plant and equipment |
47,087
32,725
2
47,087
32,725
-
2,817
3
| Trade and other receivables |
12,859
42,298
4
4,770
| Cash and cash equivalents |
-
45,115
17,629
| Trade and other payables: amounts falling due within one |
| year |
(12,190)
(115,493)
5
5,439
(70,378)
Net current liabilities
| Total assets less current liabilities |
(23,291)
38,164
| Trade and other payables: amounts falling due after more |
| than one year |
(10,000)
-
6
(23,291)
Net assets/liabilities
28,164
120,100
120,100
(143,391)
(91,936)
(23,291)
28,164
Shareholders' funds
| For the year ended 31 March 2025 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies. |
| The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006 |
| The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of |
| each financial year and of its profit or loss for each financial year in accordance with the requirements of Section |
| 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial |
| statements, so far as applicable to the company. |
| In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered. |
| The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. |
| Mr Jamie Dickinson Director |
| These financial statements were approved and authorised for issue by the Board on 18 November 2025 and were signed by: |
| The notes form part of these financial statements |
1 of 3
For the year ended 31 March 2025
Arca Biologistics Limited
Notes to the Financial Statements
Statutory Information
| Arca Biologistics Limited is a private limited company, limited by shares, domiciled in England and Wales, registration |
| number 14706868. |
Cheshire House 164 Main Road
Goostrey
Crewe
England
CW4 8JP
| The presentation currency is £ sterling. |
Basis of preparing the financial statements
| These financial statements have been prepared in accordance with the provisions of Section 1A of Financial |
| Reporting Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the |
| Companies Act 2006. The financial statements have been prepared under the historical costs convention as |
| modified by the revaluation of certain assets. |
| 2. Property, plant and equipment |
38,500
22,671
61,171
| Provision for depreciation and impairment |
5,775
Charge for year
8,309
14,084
47,087
32,725
2024
2025
2,817
-
2 of 3
For the year ended 31 March 2025
Arca Biologistics Limited
Notes to the Financial Statements Continued
| 4. Trade and other receivables |
2024
2025
34,746
10,239
7,552
2,620
12,859
42,298
| 5. Trade and other payables: amounts falling due within one year |
2024
2025
3,836
-
29,747
10,940
| Amounts owed to group undertaking and undertaking in which the |
| company has a participating interest |
20,000
-
| Taxation and social security |
2,411
-
59,499
1,250
115,493
12,190
| 6. Trade and other payables: amounts falling due after more than one year |
2024
2025
| Amounts owed to group undertaking and undertaking in which the |
| company has a participating interest |
-
10,000
| 7. Average number of persons employed |
During the year the average number of employees was 8 (2024 : 4)
3 of 3